Clinical Outcome Assessments and PROs

    Clinical Outcomes Assessments and PROs

    Dates TBC 2023, live online training


    This specifically tailored and highly interactive online training will explore the opportunities and challenges of patient centricity, as well as strategies and tactics based on high-value case examples.

    Learning Objectives

    • Explore the opportunities and challenges of a truly patient centric approach throughout the product lifecycle, starting in early development
    • Discuss strategies to accelerate clinical development and trials, patient recruitment and retention through successful patient involvement
    • Discover the newest regulatory guidance on patient experience data and patient reported outcomes for labelling claims
    • Strategize the incorporation of a PRO strategy into the clinical development, regulatory and market access strategies of a compound
    • Participate in an interactive workshop to develop a PRO strategy

    Key Topics

    • Patient Engagement and Involvement
    • Stakeholder Use of Patient and Caregiver Data
    • Patient-Reported Outcomes; PRO-Based Labelling Claims
    • PRO Strategy Development and Integration
    • PRO Strategy Co-Creation Digital Workshop

    Who should attend?

    Patients and Patient representatives, Clinical research leaders and directors, Clinical trial managers, Patient-reported outcomes and Clinical outcomes assessment scientists, Outcomes researchers and health economists, Patient engagement leads and directors, Epidemiologists and RWE experts and researchers, Regulatory executives, Pricing and market access experts, Medical affairs executives, Marketing and commercial executives

    Past participants

    • Scientist, Patient Centered Science, AstraZeneca
    • Patient Engagement Director, Ferring
    • Associate Director Patient Engagement, Novartis
    • Global Patient Partnership Director R&D, Roche

    Our online training experience includes

    • Our client zone – a single source for all training materials as well as pre and post-training communication
    • Live interactive format via the Zoom platform
    • Direct interaction with the trainer
    • Q&As, case studies, polls
    • Revisit recorded sessions for 30 days
    • Training in digital format
    • Digital and LinkedIn certificates

    Follow-up Session

    The aim of this half-day follow-up session on March 10th is to enhance the knowledge obtained by course participants on COAs, PROs, and PED in the main course with a specific focus on rare diseases, orphan drugs as well as cell and gene therapies (ATMPs). This follow-up session highlights all of the key subjects, addresses questions and includes additional topics and case examples. The Follow-up session is only available and suitable for participants, who took the main course.


    David Schwicker has biopharmaceutical consulting expertise spanning more than 25 years. Founder of ORPHA Strategy Consulting, and former Vice President with PAREXEL International in the United States. David is a sought-after expert for accelerating marketing authorization, time to launch, early patient and market access of ATMPs.
    Clinical Outcome Assessments and PROs online course agenda

    Clinical Outcomes Assessments and PROs

    Download the full training agenda to reveal complete session details, training takeaways, case studies, daily schedule, special features and full trainer bio.

    PC, microphone, camera, stable internet connection and the Zoom application.

    Yes, we will make every effort to ensure best possible interaction. You will see the slides, interact with the trainer and fellow participants. Questions and group exercises will be facilitated through the online meeting platform.

    Yes, you can transfer the registration to a colleague at any time.

    Yes, you may transfer your registration to a different event up to one month before the scheduled dates, provided the training fee has been paid in full.

    pharma learning leader

    Lydia Makori
    +421 222 200 543

    Training Details
    What participants said about this course

    "Thanks for the great session! Very educational, and for a beginner in patient engagement a lot of takeaways and things to further look into afterwards. Would recommend! :)"
    Associate Consultant, Alira Health

    "This was a great learning opportunity"
    Head of Patient Advocacy - Europe & Canada, Takeda

    "Great training!"
    Patient Engagement Manager, Novartis

    "Knowledge of the presenter and the treasure trove of reference slides - the real work begins now reviewing all the materials and links for more context."
    RWE & PROS Manager, Angelini Pharma

    "Hearing in-depth knowledge from an experienced trainer, as well as insights from fellow patient engagement professionals with different backgrounds and on different areas was great."
    Medical Epidemiologist And Real World Data Specialist, Pfizer